Crigler-Najjar syndrome arises due to lack or deficiency in the enzyme uridine diphosphate glucuronosyl transferase. Variety 1 and type two kinds of the condition have already been described. The prime objectives of management are then intense symptomatic and supportive therapy with distinct cons